|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,310,000,000 |
Market
Cap: |
72.25(B) |
Last
Volume: |
37,878,742 |
Avg
Vol: |
7,586,944 |
52
Week Range: |
$65.17 - $81.42 |
|
Level
I Sector: |
Consumer Discretionary |
Level
II Sector: |
Retail |
Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 7.4 |
Insider 3/6 Months : 8 |
|
Guru Rank Number : 214 |
Guru Rank Value : 5.7 |
Guru Occurances : 5 |
|
|
|
|
|
|
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
2,000 |
16,000 |
16,000 |
Total Buy Value |
$0 |
$140,930 |
$1,117,497 |
$1,117,497 |
Total People Bought |
0 |
1 |
2 |
2 |
Total Buy Transactions |
0 |
1 |
2 |
2 |
Total Shares Sold |
29,473 |
29,473 |
55,232 |
484,338 |
Total Sell Value |
$2,267,947 |
$2,267,947 |
$4,197,951 |
$46,038,227 |
Total People Sold |
1 |
1 |
2 |
5 |
Total Sell Transactions |
1 |
1 |
2 |
7 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rohan Karen |
President and CEO |
|
2023-05-03 |
4 |
B |
$69.75 |
$976,567 |
D/D |
14,000 |
431,392 |
2.81 |
1% |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2023-02-28 |
4 |
D |
$83.54 |
$14,954 |
D/D |
(179) |
26,151 |
|
- |
|
Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
|
2023-02-28 |
4 |
D |
$83.54 |
$10,025 |
D/D |
(120) |
4,106 |
|
- |
|
Joyner J. David |
EVP&President-PharmacyServices |
|
2023-02-28 |
4 |
A |
$83.54 |
$1,999,948 |
D/D |
23,940 |
23,940 |
|
- |
|
Khichi Samrat S. |
EVP, CPO and General Counsel |
|
2023-02-28 |
4 |
A |
$83.54 |
$3,999,979 |
D/D |
47,881 |
47,881 |
|
- |
|
Havanec Laurie P. |
EVP and Chief People Officer |
|
2023-02-27 |
4 |
D |
$85.77 |
$347,025 |
D/D |
(4,046) |
20,386 |
|
- |
|
Shah Prem S |
EVP and Co-President of Retail |
|
2023-02-27 |
4 |
D |
$85.77 |
$19,384 |
D/D |
(226) |
44,403 |
|
- |
|
Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
|
2023-02-27 |
4 |
D |
$85.77 |
$27,275 |
D/D |
(318) |
3,872 |
|
- |
|
Peluso Michelle A |
EVP and Co-President of Retail |
|
2023-02-27 |
4 |
D |
$85.77 |
$1,055,314 |
D/D |
(12,304) |
222,682 |
|
- |
|
Peluso Michelle A |
EVP and Co-President of Retail |
|
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
192,554 |
207,465 |
|
- |
|
Rohan Karen |
President and CEO |
|
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
206,610 |
206,610 |
|
- |
|
Joyner J. David |
EVP&President-PharmacyServices |
|
2023-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,672 |
|
-18% |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2022-12-31 |
4 |
D |
$93.19 |
$27,291,251 |
D/D |
(292,856) |
315,273 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2022-12-15 |
4 |
AS |
$98.24 |
$13,521,180 |
D/D |
(137,466) |
608,129 |
|
-25% |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2022-12-15 |
4 |
OE |
$62.21 |
$10,151,220 |
D/D |
137,466 |
644,619 |
|
- |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2022-12-01 |
4 |
D |
$101.65 |
$15,552 |
D/D |
(153) |
26,177 |
|
- |
|
Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
|
2022-11-29 |
4 |
D |
$100.88 |
$44,589 |
D/D |
(442) |
2,897 |
|
- |
|
Millon Jean Pierre |
Director |
|
2022-11-17 |
4 |
A |
$94.93 |
$133,092 |
D/D |
1,402 |
2,811 |
|
- |
|
Deparle Nancy Ann |
Director |
|
2022-11-17 |
4 |
A |
$94.93 |
$133,092 |
D/D |
1,402 |
26,162 |
|
- |
|
Ludwig Edward J |
Director |
|
2022-11-17 |
4 |
A |
$94.93 |
$12,436 |
D/D |
131 |
18,630 |
|
- |
|
Aguirre Fernando |
Director |
|
2022-11-17 |
4 |
A |
$94.93 |
$125,592 |
D/D |
1,323 |
28,849 |
|
- |
|
Finucane Anne A. |
Director |
|
2022-11-17 |
4 |
A |
$94.93 |
$135,560 |
D/D |
1,428 |
7,320 |
|
- |
|
Balser Jeffrey R. |
Director |
|
2022-11-17 |
4 |
A |
$94.93 |
$125,592 |
D/D |
1,323 |
1,947 |
|
- |
|
Balser Jeffrey R. |
Director |
|
2022-09-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
218 |
|
-17% |
|
Balser Jeffrey R. |
Director |
|
2022-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
406 |
624 |
|
- |
|
711 Records found
|
|
Page 3 of 29 |
|
|